Elena Lum, Ph.D.
Affiliations: | 2013 | Molecular and Cellular Biology | Stony Brook University, Stony Brook, NY, United States |
Area:
Molecular Biology, OncologyGoogle:
"Elena Lum"Parents
Sign in to add mentor| Robert Lucito | grad student | 2013 | SUNY Stony Brook | |
| (Loss of DOK2 Induces Carboplatin Resistance in Ovarian Cancer via Suppression of Apoptosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lum E, Vigliotti M, Banerjee N, et al. (2013) Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis. Gynecologic Oncology. 130: 369-76 |
| Lum E, Vigliotti M, Banerjee N, et al. (2013) Abstract 2988: DOK2 suppression by methylation induces platinum resistance via suppression of apoptosis in ovarian cancer cells. Cancer Research. 73: 2988-2988 |
| Vigliotti M, Lum E, Banerjee n, et al. (2013) Abstract A46: Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis Clinical Cancer Research. 19 |
| Cutter NL, Yacoub M, Lucito RD, et al. (2013) Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation Clinical Cancer Research. 19 |
| NLCPD, Lum E, Vigliotti M, et al. (2012) Abstract 3144: A role for DOK2 methylation in platinum resistance and tumor suppression in ovarian cancer Cancer Research. 72: 3144-3144 |
| Cutter N, Vigliotti M, Lum E, et al. (2012) Abstract 1047: Suppression of the chromatin remodeling protein CHD3 and platinum resistance in ovarian cancer Cancer Research. 72: 1047-1047 |
| Wrzeszczynski KO, Varadan V, Byrnes J, et al. (2011) Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. Plos One. 6: e28503 |